Journal of Cancer Therapy
Vol.4 No.3A(2013), Paper ID 28932, 10
pages
DOI:10.4236/jct.2013.43A058
Cell Origin Subtypes Predict Outcomes in Localized-Stage Diffuse Large B-Cell Lymphoma Treated with Curative Radiotherapy
Yuko Watanabe, Hiroaki Suefuji, Etsuyo Ogo, Kensaku Sato, Tadashi Nakashima, Takashi Okamura, Koichi Ohshima, Naofumi Hayabuchi
Department of Radiology, Kurume University School of Medicine, Kurume, Japan
Department of Radiology, Kurume University School of Medicine, Kurume, Japan
Department of Radiology, Kurume University School of Medicine, Kurume, Japan
Biostastics Center, Kurume University School of Medicine, Kurume, Japan
Department of Otolaryngology, Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan
Department of Hematology and Oncology, Kurume University School of Medicine, Kurume, Japan
Department of Pathology, Kurume University School of Medicine, Kurume, Japan
Department of Radiology, Kurume University School of Medicine, Kurume, Japan
Copyright © 2013 Yuko Watanabe, Hiroaki Suefuji, Etsuyo Ogo, Kensaku Sato, Tadashi Nakashima, Takashi Okamura, Koichi Ohshima, Naofumi Hayabuchi et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Y. Watanabe, H. Suefuji, E. Ogo, K. Sato, T. Nakashima, T. Okamura, K. Ohshima and N. Hayabuchi, "Cell Origin Subtypes Predict Outcomes in Localized-Stage Diffuse Large B-Cell Lymphoma Treated with Curative Radiotherapy,"
Journal of Cancer Therapy, Vol. 4 No. 3A, 2013, pp. 475-484. doi:
10.4236/jct.2013.43A058.